Financhill
Buy
53

CL Quote, Financials, Valuation and Earnings

Last price:
$93.53
Seasonality move :
3.21%
Day range:
$92.60 - $94.24
52-week range:
$85.32 - $109.30
Dividend yield:
2.14%
P/E ratio:
26.58x
P/S ratio:
3.83x
P/B ratio:
357.91x
Volume:
4M
Avg. volume:
5.4M
1-year change:
5.04%
Market cap:
$75.9B
Revenue:
$20.1B
EPS (TTM):
$3.52
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $16.5B $17.4B $18B $19.5B $20.1B
Revenue Growth (YoY) 4.96% 5.77% 3.13% 8.29% 3.31%
 
Cost of Revenues $6.5B $7B $7.7B $8.1B $7.9B
Gross Profit $10B $10.4B $10.2B $11.3B $12.2B
Gross Profit Margin 60.82% 59.56% 57.04% 58.21% 60.5%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6B $6.4B $6.6B $7.2B $7.7B
Other Inc / (Exp) -$64M -$723M -$804M -$461M -$149M
Operating Expenses $6.1B $6.5B $6.6B $7.2B $7.8B
Operating Income $3.9B $3.9B $3.6B $4.1B $4.3B
 
Net Interest Expenses $164M $100M $153M $232M $225M
EBT. Incl. Unusual Items $3.6B $3.1B $2.7B $3.4B $4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $787M $749M $693M $937M $907M
Net Income to Company $2.9B $2.3B $2B $2.5B $3B
 
Minority Interest in Earnings -$165M -$172M -$182M -$155M -$160M
Net Income to Common Excl Extra Items $2.7B $2.2B $1.8B $2.3B $2.9B
 
Basic EPS (Cont. Ops) $3.15 $2.56 $2.13 $2.78 $3.53
Diluted EPS (Cont. Ops) $3.14 $2.55 $2.13 $2.77 $3.51
Weighted Average Basic Share $856.8M $845M $836.4M $827.4M $819.1M
Weighted Average Diluted Share $859.3M $848.3M $838.8M $829.2M $823.2M
 
EBITDA $4.4B $3.8B $3.4B $4.2B $4.9B
EBIT $3.8B $3.2B $2.8B $3.7B $4.2B
 
Revenue (Reported) $16.5B $17.4B $18B $19.5B $20.1B
Operating Income (Reported) $3.9B $3.9B $3.6B $4.1B $4.3B
Operating Income (Adjusted) $3.8B $3.2B $2.8B $3.7B $4.2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $4.3B $4.4B $4.6B $5B $4.9B
Revenue Growth (YoY) 7.7% 1.83% 5.13% 6.94% -0.1%
 
Cost of Revenues $1.7B $1.8B $2.1B $2B $2B
Gross Profit $2.6B $2.6B $2.6B $3B $3B
Gross Profit Margin 61.12% 58.12% 55.61% 59.6% 60.3%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.6B $1.6B $1.6B $1.8B $1.9B
Other Inc / (Exp) -$8M -$671M -$739M -$123M -$82M
Operating Expenses $1.7B $1.6B $1.6B $1.8B $1.9B
Operating Income $959M $943M $926M $1.2B $1.1B
 
Net Interest Expenses $57M -- $55M $62M $50M
EBT. Incl. Unusual Items $894M $324M $132M $988M $993M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $202M $136M $89M $228M $214M
Net Income to Company $692M $188M $43M $760M $779M
 
Minority Interest in Earnings -$45M -$40M -$38M -$42M -$40M
Net Income to Common Excl Extra Items $647M $148M $5M $718M $739M
 
Basic EPS (Cont. Ops) $0.76 $0.18 $0.01 $0.87 $0.91
Diluted EPS (Cont. Ops) $0.75 $0.18 $0.01 $0.87 $0.90
Weighted Average Basic Share $854.1M $842.3M $832.5M $823.2M $816.1M
Weighted Average Diluted Share $858.7M $846.2M $834M $825.3M $820.2M
 
EBITDA $1.1B $379M $271M $917M $1.2B
EBIT $914M $237M $136M $767M $1B
 
Revenue (Reported) $4.3B $4.4B $4.6B $5B $4.9B
Operating Income (Reported) $959M $943M $926M $1.2B $1.1B
Operating Income (Adjusted) $914M $237M $136M $767M $1B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $16.5B $17.4B $18B $19.5B $20.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6.5B $7B $7.7B $8.1B $7.9B
Gross Profit $10B $10.4B $10.2B $11.3B $12.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6B $6.4B $6.6B $7.2B $7.7B
Other Inc / (Exp) -$64M -$723M -$804M -$461M -$149M
Operating Expenses $6.1B $6.5B $6.6B $7.2B $7.8B
Operating Income $3.9B $3.9B $3.6B $4.1B $4.3B
 
Net Interest Expenses $164M $100M $153M $232M $224M
EBT. Incl. Unusual Items $3.6B $3.1B $2.7B $3.4B $4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $787M $749M $693M $937M $905M
Net Income to Company $2.9B $2.3B $2B $2.5B $3B
 
Minority Interest in Earnings -$165M -$172M -$182M -$155M -$161M
Net Income to Common Excl Extra Items $2.7B $2.2B $1.8B $2.3B $2.9B
 
Basic EPS (Cont. Ops) $3.14 $2.56 $2.14 $2.79 $3.53
Diluted EPS (Cont. Ops) $3.13 $2.56 $2.13 $2.78 $3.52
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $4.4B $3.8B $3.4B $4.2B $4.9B
EBIT $3.8B $3.2B $2.8B $3.7B $4.2B
 
Revenue (Reported) $16.5B $17.4B $18B $19.5B $20.1B
Operating Income (Reported) $3.9B $3.9B $3.6B $4.1B $4.3B
Operating Income (Adjusted) $3.8B $3.2B $2.8B $3.7B $4.2B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $17.4B $18B $19.5B $20.1B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $7B $7.7B $8.1B $7.9B --
Gross Profit $10.4B $10.2B $11.3B $12.2B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6.4B $6.6B $7.2B $7.7B --
Other Inc / (Exp) -$723M -$804M -$461M -$149M --
Operating Expenses $6.5B $6.6B $7.2B $7.8B --
Operating Income $3.9B $3.6B $4.1B $4.3B --
 
Net Interest Expenses $152M $153M $232M $224M --
EBT. Incl. Unusual Items $3.1B $2.7B $3.4B $4B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $749M $693M $937M $905M --
Net Income to Company $2.3B $2B $2.5B $3B --
 
Minority Interest in Earnings -$172M -$182M -$155M -$161M --
Net Income to Common Excl Extra Items $2.2B $1.8B $2.3B $2.9B --
 
Basic EPS (Cont. Ops) $2.56 $2.14 $2.79 $3.53 --
Diluted EPS (Cont. Ops) $2.56 $2.13 $2.78 $3.52 --
Weighted Average Basic Share $3.4B $3.3B $3.3B $3.3B --
Weighted Average Diluted Share $3.4B $3.4B $3.3B $3.3B --
 
EBITDA $3.8B $3.4B $4.2B $4.9B --
EBIT $3.2B $2.8B $3.7B $4.2B --
 
Revenue (Reported) $17.4B $18B $19.5B $20.1B --
Operating Income (Reported) $3.9B $3.6B $4.1B $4.3B --
Operating Income (Adjusted) $3.2B $2.8B $3.7B $4.2B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $888M $832M $775M $966M $1.1B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.3B $1.3B $1.5B $1.6B $1.5B
Inventory $1.7B $1.7B $2.1B $1.9B $2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $513M $576M $760M $793M $713M
Total Current Assets $4.3B $4.4B $5.1B $5.3B $5.3B
 
Property Plant And Equipment $3.7B $3.7B $4.3B $4.6B $4.4B
Long-Term Investments -- -- -- -- --
Goodwill $3.8B $3.3B $3.4B $3.4B $3.3B
Other Intangibles $2.9B $2.5B $1.9B $1.9B $1.8B
Other Long-Term Assets $857M $974M $904M $1B $1.1B
Total Assets $15.9B $15B $15.7B $16.4B $16B
 
Accounts Payable $1.4B $1.5B $1.6B $1.7B $1.8B
Accrued Expenses $1.9B $1.7B $1.8B $2B $2.1B
Current Portion Of Long-Term Debt $267M $51M $25M $330M $660M
Current Portion Of Capital Lease Obligations $137M $137M $108M $95M $107M
Other Current Liabilities $93M $6M $15M $26M $23M
Total Current Liabilities $4.4B $4.1B $4B $4.7B $5.8B
 
Long-Term Debt $7.3B $7.2B $8.7B $8.2B $7.3B
Capital Leases -- -- -- -- --
Total Liabilities $14.8B $14.1B $14.9B $15.4B $15.5B
 
Common Stock $1.5B $1.5B $1.5B $1.5B $1.5B
Other Common Equity Adj -$4.3B -$4.4B -$4.1B -$3.9B -$4.2B
Common Equity $743M $609M $401M $609M $212M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $358M $362M $405M $348M $332M
Total Equity $1.1B $971M $806M $957M $544M
 
Total Liabilities and Equity $15.9B $15B $15.7B $16.4B $16B
Cash and Short Terms $888M $832M $775M $966M $1.1B
Total Debt $7.6B $7.2B $8.8B $8.5B $7.9B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $888M $832M $775M $966M $1.1B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.3B $1.3B $1.5B $1.6B $1.5B
Inventory $1.7B $1.7B $2.1B $1.9B $2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $513M $576M $760M $793M $713M
Total Current Assets $4.3B $4.4B $5.1B $5.3B $5.3B
 
Property Plant And Equipment $3.7B $3.7B $4.3B $4.6B $4.4B
Long-Term Investments -- -- -- -- --
Goodwill $3.8B $3.3B $3.4B $3.4B $3.3B
Other Intangibles $2.9B $2.5B $1.9B $1.9B $1.8B
Other Long-Term Assets $857M $974M $904M $1B $1.1B
Total Assets $15.9B $15B $15.7B $16.4B $16B
 
Accounts Payable $1.4B $1.5B $1.6B $1.7B $1.8B
Accrued Expenses $1.9B $1.7B $1.8B $2B $2.1B
Current Portion Of Long-Term Debt $267M $51M $25M $330M $660M
Current Portion Of Capital Lease Obligations $137M $137M $108M $95M $107M
Other Current Liabilities $93M $6M $15M $26M $23M
Total Current Liabilities $4.4B $4.1B $4B $4.7B $5.8B
 
Long-Term Debt $7.3B $7.2B $8.7B $8.2B $7.3B
Capital Leases -- -- -- -- --
Total Liabilities $14.8B $14.1B $14.9B $15.4B $15.5B
 
Common Stock $1.5B $1.5B $1.5B $1.5B $1.5B
Other Common Equity Adj -$4.3B -$4.4B -$4.1B -$3.9B -$4.2B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $358M $362M $405M $348M $332M
Total Equity $1.1B $971M $806M $957M $544M
 
Total Liabilities and Equity $15.9B $15B $15.7B $16.4B $16B
Cash and Short Terms $888M $832M $775M $966M $1.1B
Total Debt $7.6B $7.2B $8.8B $8.5B $7.9B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $2.9B $2.3B $2B $2.5B $3B
Depreciation & Amoritzation $539M $556M $545M $567M $605M
Stock-Based Compensation $107M $135M $125M $122M $135M
Change in Accounts Receivable $138M -$84M -$227M -$37M -$56M
Change in Inventories -$251M -$72M -$333M $194M -$100M
Cash From Operations $3.7B $3.3B $2.6B $3.7B $4.1B
 
Capital Expenditures $410M $567M $696M $705M $561M
Cash Acquisitions -$353M -- -$809M -- --
Cash From Investing -$779M -$592M -$1.6B -$742M -$534M
 
Dividends Paid (Ex Special Dividend) -$1.7B -$1.7B -$1.7B -$1.7B -$1.8B
Special Dividend Paid
Long-Term Debt Issued -- $699M $1.5B $1.5B $2M
Long-Term Debt Repaid -$1.1B -$703M -$406M -$903M -$503M
Repurchase of Common Stock -$1.5B -$1.3B -$1.3B -$1.1B -$1.7B
Other Financing Activities -$66M -$24M -$18M $18M -$91M
Cash From Financing -$2.9B -$2.8B -$952M -$2.8B -$3.4B
 
Beginning Cash (CF) $883M $888M $832M $775M $966M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $21M -$41M $3M $210M $184M
Ending Cash (CF) $888M $832M $775M $966M $1.1B
 
Levered Free Cash Flow $3.3B $2.8B $1.9B $3B $3.5B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $728M $603M $414M $729M --
Depreciation & Amoritzation $137M $138M $128M $150M --
Stock-Based Compensation $38M $29M $14M $19M --
Change in Accounts Receivable -$170M -$197M -$57M -$252M --
Change in Inventories -$40M -$215M -$24M $11M --
Cash From Operations $598M $386M $735M $681M --
 
Capital Expenditures $107M $122M $163M $126M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$142M -$141M -$264M -$193M --
 
Dividends Paid (Ex Special Dividend) -$376M -$378M -$390M -$394M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $25M $5M $1.5B $1M --
Long-Term Debt Repaid -- -- -$500M -$500M --
Repurchase of Common Stock -$372M -$410M -$180M -$509M --
Other Financing Activities -$6M -$5M $5M -$23M --
Cash From Financing -$334M -$204M -$375M -$361M --
 
Beginning Cash (CF) $888M $832M $775M $966M --
Foreign Exchange Rate Adjustment -$15M $4M -$4M -$14M --
Additions / Reductions $122M $41M $96M $127M --
Ending Cash (CF) $995M $877M $867M $1.1B --
 
Levered Free Cash Flow $491M $264M $572M $555M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $2.9B $2.3B $2B $2.5B $3B
Depreciation & Amoritzation $539M $556M $545M $567M $605M
Stock-Based Compensation $107M $135M $125M $122M $135M
Change in Accounts Receivable $138M -$84M -$227M -$37M -$56M
Change in Inventories -$251M -$72M -$333M $194M -$100M
Cash From Operations $3.7B $3.3B $2.6B $3.7B $4.1B
 
Capital Expenditures $410M $567M $696M $705M $561M
Cash Acquisitions -$353M -- -$809M -- --
Cash From Investing -$779M -$592M -$1.6B -$742M -$534M
 
Dividends Paid (Ex Special Dividend) -$1.7B -$1.7B -$1.7B -$1.7B -$1.8B
Special Dividend Paid
Long-Term Debt Issued -- $699M $1.5B $1.5B $2M
Long-Term Debt Repaid -- -- -$406M -$903M -$503M
Repurchase of Common Stock -$1.5B -$1.3B -$1.3B -$1.1B -$1.7B
Other Financing Activities -$66M -$24M -$18M $18M -$91M
Cash From Financing -$2.9B -$2.8B -$952M -$2.8B -$3.4B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $21M -$41M $3M $210M $184M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $3.3B $2.8B $1.9B $3B $3.5B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $728M $603M $414M $729M --
Depreciation & Amoritzation $137M $138M $128M $150M --
Stock-Based Compensation $38M $29M $14M $19M --
Change in Accounts Receivable -$170M -$197M -$57M -$252M --
Change in Inventories -$40M -$215M -$24M $11M --
Cash From Operations $598M $386M $735M $681M --
 
Capital Expenditures $107M $122M $163M $126M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$142M -$141M -$264M -$193M --
 
Dividends Paid (Ex Special Dividend) -$376M -$378M -$390M -$394M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $25M $5M $1.5B $1M --
Long-Term Debt Repaid -- -- -$500M -$500M --
Repurchase of Common Stock -$372M -$410M -$180M -$509M --
Other Financing Activities -$6M -$5M $5M -$23M --
Cash From Financing -$334M -$204M -$375M -$361M --
 
Beginning Cash (CF) $888M $832M $775M $966M --
Foreign Exchange Rate Adjustment -$15M $4M -$4M -$14M --
Additions / Reductions $122M $41M $96M $127M --
Ending Cash (CF) $995M $877M $867M $1.1B --
 
Levered Free Cash Flow $491M $264M $572M $555M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Should I Buy Alcoa Stock?
Should I Buy Alcoa Stock?

Alcoa (AA) finds itself in an interesting position in early…

Where Will Nu Holdings Stock Be in 2030?
Where Will Nu Holdings Stock Be in 2030?

Despite fast growth, high profitability and an extraordinary runway ahead,…

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
44
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Buy
54
NUTX alert for Apr 3

Nutex Health [NUTX] is up 5.41% over the past day.

Buy
52
PVH alert for Apr 3

PVH [PVH] is up 1.81% over the past day.

Sell
15
PCVX alert for Apr 3

Vaxcyte [PCVX] is up 4.47% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock